Coherus Oncology (CHRS) Receivables - Other (2013 - 2026)
Coherus Oncology (CHRS) posted Receivables - Other of $446000.0 for Q1 2026, down 26.04% sequentially from $603000.0 in Q4 2025, and down 77.1% YoY from $1.9 million in Q1 2025.
Coherus Oncology (CHRS) Receivables - Other (2013 - 2026) Analysis & Trends
Coherus Oncology has reported Receivables - Other for 6 years, with the latest figure at $446000.0 in Q1 2026.
- Quarterly Receivables - Other fell 77.1% year-over-year to $446000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $446000.0 (down 77.1% YoY) and the FY2025 annual result came in at $603000.0, down 94.52% from the prior year.
- Receivables - Other fell to $446000.0 in Q1 2026 per CHRS's latest filing, from $603000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $241.3 million in Q3 2025 and troughed at $446000.0 in Q1 2026.
- A 3-year average of $63.5 million and a median of $31.2 million in 2024 frame the typical range for Receivables - Other.
- The widest YoY moves for Receivables - Other: up 672.23% in 2025, down 94.52% in 2025.
- Over 3 years, Receivables - Other stood at $11.0 million in 2024, then tumbled by 94.52% to $603000.0 in 2025, then declined by 26.04% to $446000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $446000.0, $603000.0, and $241.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - |
| 10 | Coherus Oncology | 212.87 Mn | 107.57 Mn | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 372,000.00 |
| Jun 30, 2026 | 372,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 603,000.00 |
| Dec 31, 2025 | 603,000.00 |
| Sep 30, 2025 | 241.25 Mn |
| Sep 30, 2025 | 241.25 Mn |
| Jun 30, 2025 | 114.53 Mn |
| Jun 30, 2025 | 114.53 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 11.01 Mn |
| Dec 31, 2024 | 11.01 Mn |
| Sep 30, 2024 | 31.24 Mn |
| Sep 30, 2024 | 31.24 Mn |
| Jun 30, 2024 | 138.32 Mn |
| Jun 30, 2024 | 138.32 Mn |
| Mar 31, 2024 | 32.19 Mn |
| Mar 31, 2024 | 32.19 Mn |